Jane Street Group, LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $75.4 Million - $88.4 Million	73,600 New	73,600 $77.4 Million
Q1 2022 May 17, 2022	SELL	$595.12 - $698.43 $35.6 Million - $41.8 Million	-59,900 Reduced 44.73%	74,000 $51.7 Million
Q4 2021 Feb 15, 2022	SELL	$543.48 - $670.97 $3.48 Million - $4.29 Million	-6,400 Reduced 4.56%	133,900 $84.6 Million
Q3 2021 Nov 16, 2021	BUY	$574.03 - $680.96 $3.16 Million - $3.75 Million	5,500 Added 4.08%	140,300 $84.9 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $22.2 Million - $26.2 Million	46,900 Added 53.36%	134,800 $75.3 Million
Q1 2021 May 18, 2021	SELL	$446.73 - $548.2 $1.25 Million - $1.53 Million	-2,800 Reduced 3.09%	87,900 $41.6 Million
Q4 2020 Feb 17, 2021	BUY	$478.3 - $607.98 $15.4 Million - $19.5 Million	32,100 Added 54.78%	90,700 $43.8 Million
Q3 2020 Nov 17, 2020	SELL	$544.75 - $658.21 $7.46 Million - $9.02 Million	-13,700 Reduced 18.95%	58,600 $32.8 Million
Q2 2020 Aug 17, 2020	SELL	$493.32 - $643.92 $33.2 Million - $43.3 Million	-67,200 Reduced 48.17%	72,300 $45.1 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $33.6 Million - $49.4 Million	99,900 Added 252.27%	139,500 $68.1 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $3.02 Million - $4.14 Million	11,000 Added 38.46%	39,600 $14.9 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $929,763 - $1.08 Million	3,400 Added 13.49%	28,600 $7.93 Million
Q2 2019 Aug 15, 2019	BUY	$299.6 - $414.82 $149,800 - $207,410	500 Added 2.02%	25,200 $7.89 Million
Q1 2019 May 16, 2019	BUY	$372.08 - $439.57 $186,040 - $219,785	500 Added 2.07%	24,700 $10.1 Million
Q4 2018 Feb 15, 2019	BUY	$335.82 - $403.04 $2.79 Million - $3.35 Million	8,300 Added 52.2%	24,200 $9.04 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $8.15 Million - $9.48 Million	-23,200 Reduced 59.34%	15,900 $6.42 Million
Q2 2018 Aug 15, 2018	BUY	$284.6 - $344.99 $2.73 Million - $3.31 Million	9,600 Added 32.54%	39,100 $13.5 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $97.2 Million - $121 Million	-307,700 Reduced 91.25%	29,500 $10.2 Million
Q4 2017 Feb 15, 2018	BUY	$358.63 - $469.95 $114 Million - $149 Million	317,200 Added 1586.0%	337,200 $127 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $8.63 Million - $10.1 Million	20,000	20,000 $8.94 Million

Others Institutions Holding REGN

# of Institutions

1,500

Shares Held

83M

Call Options Held

1.22M

Put Options Held

1.5M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account